Celator Pharmaceuticals Inc 4
4 · Celator Pharmaceuticals Inc · Filed Dec 7, 2015
Insider Transaction Report
Form 4
Morenstein Scott D
Director
Transactions
- Purchase
Common Stock
2015-12-03$1.86/sh+5,000$9,325→ 6,277 total
Footnotes (2)
- [F1]This constitutes the weighted average purchase price. The prices range from $1.85 to $1.8693. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]These securities are owned by Scott D. Morenstein, who is the Reporting Person. The 1,123,612 shares of common stock previously reported on the Reporting Person's Form 4 are no longer being included because the Reporting Person does not have beneficial ownership of these securities.